![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Adaptimmune reports updated SURPASS data at ESMO 2021 (Adaptimmune Therapeutics) View |
![]() |
SITC 2020 - Adaptimmune's SURPASS Poster (Adaptimmune Therapeutics) View |
![]() |
#ESMO21 Expert Video Report on head and neck cancer (European Society for Medical Oncology (ESMO)) View |
![]() |
Adaptimmune Therapeutics shares update on its late-stage clinical pipeline assets to treat cancer (Proactive Investors) View |
![]() |
Adaptimmune (Alliance for Regenerative Medicine) View |
![]() |
SURPASS-2: investing ADP-A2M4CD8 SPEAR T-cell therapy to treat esophageal and GEJ cancers (VJOncology) View |
![]() |
INVESTORS ARE EXCITED ABOUT THIS MASSIVE DEAL - ADAP STOCK ADAPTIMMUNE THERAPEUTICS HUGE GAINS (IAMJERM - CS2) View |
![]() |
CT053, anti-GPC3 CAR-T and targeting solid tumors (VJRegenMed) View |
![]() |
() View |
![]() |
() View |